Disruption of hippocampal upstream regulators of mTOR and insulin pathways in Down syndrome with Alzheimer's disease neuropathology: Preliminary observations
What this study shows
Spatial transcriptomics plus localized proteomics on human post-mortem hippocampus show that mTOR pathway signalling is significantly altered in specific hippocampal subfields in Down syndrome with Alzheimer's disease neuropathology, while insulin pathway signalling is altered specifically in dentate granule neurons — pointing to subregion- and cell-type-specific mTOR/insulin dysregulation rather than a uniform whole-tissue shift. Explicitly framed by the authors as preliminary.
At a glance
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: Human post-mortem hippocampus (Down syndrome with AD neuropathology vs neurotypical controls)) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | Human post-mortem hippocampus (Down syndrome with AD neuropathology vs neurotypical controls) |
| Journal | Alzheimer's & Dementia |
| Year | 2026 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1002/alz.71776 · PMID 42635110 · Free full text (PMC13501503) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | none (observational post-mortem comparison) |
| Target | mTOR and insulin signalling pathways across hippocampal subfields |
| Model | human post-mortem hippocampus (Down syndrome with Alzheimer's neuropathology versus age-matched neurotypical controls) |
| Effect | mTOR pathway signalling differed in specific hippocampal subfields and insulin pathway signalling in dentate granule neurons, reported by the authors as preliminary. |
In the Atlas
Related topics
More studies on this topic
- Rapamycin increases cerebral blood flow and modulates metabolic, inflammatory, and microbiome profiles in healthy middle-aged APOE4 carriers: a pilot single-arm trial. (2026)
- Restriction of individual branched-chain amino acids has distinct effects on the development and progression of Alzheimer's disease in 3xTg mice (2026)
- Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. (2010)
- Aberrant excitatory neuronal ERBB4 promotes Alzheimer's disease pathology (2026)
Thank you. Your answer was counted anonymously.